Browsing: Cancer

Pralsetinib: Targeted Therapies for RET-Fusion Positive NSCLC

By KayeAugust 25, 20220

Pralsetinib is a RET receptor tyrosine kinase inhibitor used to treat metastatic RET-driven non-small cell lung cancer. Learn more

Nasopharyngeal Cancer: A Disease More Prevalent Among Asians

By Kopal SinghalAugust 22, 20220

Nasopharyngeal Cancer (NPC) is rare cancer affecting the nasopharynx area where 80% of cases are reported from Asia. Learn more

Southeast Asia: Highest Mortality Rate for Tongue Cancer

By Kopal SinghalAugust 15, 20220

Southeast Asia is one out of two regions that report the highest incidence and mortality rates of tongue cancer. Read more

Doctor On Call (DOC): Dr Steven Tucker – Cancer Screening & Prevention – Making It Personal (Part 2)

By Marie ChenAugust 12, 20220

Dr Steven Tucker answers audience questions live on our Doctor-On-Call webinar, on cancer screening & prevention, genetic testing and more!

Thalidomide (Old Drug for New Indication: Multiple Myeloma)

By KayeAugust 11, 20220

Thalidomide possesses immunomodulatory, anti-inflammatory and antiangiogenic effects. Find out why it is effective against Myeloma cells

Doctor On Call (DOC): Dr Steven Tucker – Cancer Screening & Prevention – Making It Personal (Part 1)

By Marie ChenAugust 9, 20220

Early diagnosis through cancer screening can offer a better chance of cure, and preventive care can reduce the risk of getting cancer in the first place.

Tepotinib (Tepmetko) for METex14-altered NSCLC

By KayeJuly 27, 20220

Tepotinib (Tepmetko) was recently approved for the use of Non-Small Cell Lung Cancer (NSCLC). We break down the results of Phase II VISION trial in this article.

Immune Checkpoint Inhibitors in Oncology: Pembrolizumab (Keytruda)

By KayeJuly 14, 20221

Immune Checkpoint Inhibitors in Oncology: Nivolumab (Opdivo)

By KayeJune 16, 20220

HSA Approves First-In-Class Sacituzumab Govitecan (Trodelvy) for Metastatic Triple Negative Breast Cancer (mTNBC)

By KayeMay 19, 20220

Copyright © Medical Channel Asia 2024. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

What's Hot

“I Was Almost Depressed”: How Severe Eczema Turned Carol’s Life Upside Down

Is High Protein Always Better? What Science Actually Says

AI in the Heart Room

Browsing: Cancer

Pralsetinib: Targeted Therapies for RET-Fusion Positive NSCLC

Nasopharyngeal Cancer: A Disease More Prevalent Among Asians

Southeast Asia: Highest Mortality Rate for Tongue Cancer

Doctor On Call (DOC): Dr Steven Tucker – Cancer Screening & Prevention – Making It Personal (Part 2)

Thalidomide (Old Drug for New Indication: Multiple Myeloma)

Doctor On Call (DOC): Dr Steven Tucker – Cancer Screening & Prevention – Making It Personal (Part 1)

Tepotinib (Tepmetko) for METex14-altered NSCLC

Immune Checkpoint Inhibitors in Oncology: Pembrolizumab (Keytruda)

Immune Checkpoint Inhibitors in Oncology: Nivolumab (Opdivo)

HSA Approves First-In-Class Sacituzumab Govitecan (Trodelvy) for Metastatic Triple Negative Breast Cancer (mTNBC)

“I Was Almost Depressed”: How Severe Eczema Turned Carol’s Life Upside Down

Is High Protein Always Better? What Science Actually Says

AI in the Heart Room

World Cup 2026: The Orthopaedic Toll Of Football’s Biggest Stage

Subscribe to Updates

What's Hot

Browsing: Cancer

Subscribe to Updates